Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
45.04
+4.11 (10.04%)
At close: Apr 10, 2026, 4:00 PM EDT
45.58
+0.54 (1.20%)
After-hours: Apr 10, 2026, 7:21 PM EDT
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $3.21 billion as of April 10, 2026. Its market cap has increased by 87.07% in one year.
Market Cap
3.21B
Enterprise Value
2.58B
1-Year Change
87.07%
Ranking
Category
Stock Price
$45.04
Market Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $3.21B, an increase of 1,326.65%. That is a compound annual growth rate of 71.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 2.92B | -18.75% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
| May 14, 2021 | 225.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 3.52B |
| Telix Pharmaceuticals | 3.52B |
| Legend Biotech | 3.36B |
| Tarsus Pharmaceuticals | 3.09B |
| Dyne Therapeutics | 3.08B |
| Denali Therapeutics | 3.05B |
| Catalyst Pharmaceuticals | 3.05B |
| Arcutis Biotherapeutics | 3.00B |